Loading...

Journey Medical Corporation

DERM•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$5.15
$0.02(0.39%)
U.S. Market opens in NaNh NaNm

Journey Medical Corporation (DERM) Stock Overview

Explore Journey Medical Corporation’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap126.2M
P/E Ratio-11.02
EPS (TTM)$-0.47
ROE-0.46%
Fundamental Analysis

AI Price Forecasts

1 Month$9.32
3 Months$10.52
1 Year Target$10.10

DERM Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Journey Medical Corporation (DERM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 40.15, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $10.10.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -11.02 and a market capitalization of 126.2M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.39%
5-Day Change
-2.65%
1-Month Change
-25.47%
3-Month Change
-40.67%
6-Month Change
-30.97%
Year-to-Date (YTD) Change
-33.20%
1-Year Change
-31.88%
3-Year Change
217.90%
5-Year Change
-45.79%
All-Time (Max) Change
-45.79%

Contact Information

https://journeymedicalcorp.com
480 434 6670
9237 East Via de Ventura Boulevard, Scottsdale, AZ, 85258

Company Facts

41 Employees
IPO DateNov 12, 2021
CountryUS
Actively Trading

Frequently Asked Questions